{"id":"https://openalex.org/W3198295916","doi":"https://doi.org/10.1089/jop.2021.0059","title":"N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis Pigmentosa","display_name":"N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis Pigmentosa","publication_year":2021,"publication_date":"2021-09-07","ids":{"openalex":"https://openalex.org/W3198295916","doi":"https://doi.org/10.1089/jop.2021.0059","mag":"3198295916","pmid":"https://pubmed.ncbi.nlm.nih.gov/34491833"},"language":"en","primary_location":{"id":"doi:10.1089/jop.2021.0059","doi":"https://doi.org/10.1089/jop.2021.0059","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.2021.0059","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058961724","display_name":"Marco A. Zarbin","orcid":"https://orcid.org/0000-0002-7811-7132","observed_orcids":["https://orcid.org/0000-0002-7811-7132"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]},{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco A. Zarbin","raw_affiliation_strings":["Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, New Jersey, USA","institution_ids":["https://openalex.org/I102322142","https://openalex.org/I4402554120"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086953802","display_name":"Gary D. Novack","orcid":"https://orcid.org/0000-0002-9699-8543","observed_orcids":["https://orcid.org/0000-0002-9699-8543"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gary Novack","raw_affiliation_strings":["Department of Ophthalmology & Visual Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA","PharmaLogic Development, Inc., San Rafael, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology & Visual Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA","institution_ids":["https://openalex.org/I84218800"]},{"raw_affiliation_string":"PharmaLogic Development, Inc., San Rafael, California, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5086953802"],"corresponding_institution_ids":["https://openalex.org/I84218800"],"apc_list":null,"apc_paid":null,"fwci":0.3719,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.6070776,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"37","issue":"9","first_page":"495","last_page":"501"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.04569999873638153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-of-1-trials","display_name":"N-of-1 trials","score":0.9639999866485596},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.9470000267028809},{"id":"https://openalex.org/keywords/retinitis-pigmentosa","display_name":"retinitis pigmentosa","score":0.9929999709129333},{"id":"https://openalex.org/keywords/inherited-retinal-disease","display_name":"inherited retinal disease","score":0.9079999923706055},{"id":"https://openalex.org/keywords/clinical-trial-feasibility","display_name":"clinical trial feasibility","score":0.7369999885559082},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2781114197","wikidata":"https://www.wikidata.org/wiki/Q847057","display_name":"Retinitis pigmentosa","level":3,"score":0.7584110498428345},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7442873120307922},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.734230637550354},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6374086141586304},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3235437273979187},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.31786245107650757},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.258454293012619},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23587659001350403}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012164","descriptor_name":"Retinal Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/jop.2021.0059","doi":"https://doi.org/10.1089/jop.2021.0059","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.2021.0059","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:34491833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34491833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1503104403","https://openalex.org/W1510288999","https://openalex.org/W1524110242","https://openalex.org/W1525060699","https://openalex.org/W1785759883","https://openalex.org/W1967250142","https://openalex.org/W1986126870","https://openalex.org/W1988778209","https://openalex.org/W1993351059","https://openalex.org/W1997550127","https://openalex.org/W1999052038","https://openalex.org/W2013178875","https://openalex.org/W2092170412","https://openalex.org/W2099108621","https://openalex.org/W2123056398","https://openalex.org/W2133197025","https://openalex.org/W2142330001","https://openalex.org/W2194139052","https://openalex.org/W2315378999","https://openalex.org/W2317269439","https://openalex.org/W2318131103","https://openalex.org/W2318763565","https://openalex.org/W2400686699","https://openalex.org/W2558320693","https://openalex.org/W2752226638","https://openalex.org/W2759013304","https://openalex.org/W2905619698","https://openalex.org/W2943873066","https://openalex.org/W2988329983","https://openalex.org/W2993879222","https://openalex.org/W3007287716","https://openalex.org/W3113358009","https://openalex.org/W3124318410","https://openalex.org/W3133478059","https://openalex.org/W3165641579","https://openalex.org/W4211099883"],"related_works":["https://openalex.org/W2342819438","https://openalex.org/W2093876149","https://openalex.org/W4281701176","https://openalex.org/W4394853104","https://openalex.org/W4231167984","https://openalex.org/W4404038356","https://openalex.org/W3215591742","https://openalex.org/W7052316503","https://openalex.org/W4249412152","https://openalex.org/W7216112317"],"abstract_inverted_index":{"N-of-1":[0,92],"trials":[1,8,33,58,93,102],"are":[2,19],"randomized,":[3],"prospective,":[4],"controlled,":[5],"multiple":[6],"crossover":[7],"in":[9],"a":[10,36,71],"single":[11],"patient.":[12],"Effects":[13],"of":[14,100],"one":[15],"or":[16,48],"more":[17],"treatments":[18,28,40],"studied":[20],"by":[21,53],"following":[22],"individual":[23],"patients":[24,104],"who":[25],"receive":[26],"alternative":[27],"(eg,":[29],"therapeutic":[30],"intervention).":[31],"Such":[32],"may":[34,94],"provide":[35],"path":[37],"to":[38,47,76],"assess":[39],"for":[41,103],"rare":[42,106],"diseases":[43],"with":[44,105],"rigor":[45],"equal":[46],"greater":[49],"than":[50],"that":[51,60,73,80,91],"afforded":[52],"parallel":[54],"group":[55],"randomized":[56],"clinical":[57,101],"provided":[59],"the":[61,67,77,88,96],"condition":[62],"is":[63],"reasonably":[64],"stable":[65],"during":[66],"trial":[68],"and":[69,79,98],"has":[70],"sign/symptom":[72],"responds":[74],"reversibly":[75],"therapy":[78],"can":[81],"be":[82],"measured":[83],"repeatedly.":[84],"In":[85],"this":[86],"article,":[87],"authors":[89],"propose":[90],"improve":[95],"feasibility":[97],"affordability":[99],"inherited":[107],"retinal":[108],"diseases.":[109]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-09-13T00:00:00"}